Stock listing

Cardiol Therapeutics Inc. Class A (A2PA9E) Stock Price, News, Filings & Events

Selected listing: A2PA9E · LSX · EUR · DE

A2PA9E:LSX is the listing for Cardiol Therapeutics Inc. Class A, a Canadian public company dedicated to developing innovative therapies for cardiovascular diseases. With a market capitalization of around €122.3 million, Cardiol is focused on addressing significant unmet medical needs through its research and development initiatives. The company is actively involved in advancing its pipeline and may provide updates through news releases and regulatory filings. Investors can stay informed about upcoming events and market developments related to Cardiol's progress in the cardiovascular sector.

websiteA2PA9E:LSXEURDESEO content: aiUpdated June 24, 2026/stock/lsx-a2pa9e/cardiol-therapeutics-inc-class-a/l-gnfsj3oodm
Cardiol Therapeutics Inc. Class A logo
Ticker
A2PA9E:LSX
Asset type
Stock
Market cap
$122.3M
Sector
Health Technology
Industry
Biotechnology
Exchange
LSX
Currency
EUR

Cardiol Therapeutics Inc. Class A A2PA9E:LSX stock context

A2PA9E:LSX is the listing for Cardiol Therapeutics Inc. Class A, a Canadian public company dedicated to developing innovative therapies for cardiovascular diseases. With a market capitalization of around €122.3 million, Cardiol is focused on addressing significant unmet medical needs through its research and development initiatives. The company is actively involved in advancing its pipeline and may provide updates through news releases and regulatory filings. Investors can stay informed about upcoming events and market developments related to Cardiol's progress in the cardiovascular sector.

Research Cardiol Therapeutics Inc. Class A

Alternate listings